Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meindert N Sosef

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|March 1, 2023
Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: A population-based studySteven C Kuijper, Marieke Pape, Pauline A J Vissers, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 5, 2020
Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fieldsWillem J Koemans, Ruben T H M Larue, Maximilian Kloft, et al.
BMC Surgery|January 14, 2011
Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial)Surya Say Biere, Kirsten W Maas, Luigi Bonavina, et al.
The Annals of Thoracic Surgery|December 16, 2014
Leaving a mobilized thoracic esophagus in situ when incurable cancer is discovered intraoperativelyTeus J Weijs, Eelke L A Toxopeus, Jelle P Ruurda, et al.
JMIR Research Protocols|June 30, 2015
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and ProtocolBo Jan Noordman, Joel Shapiro, Manon Cw Spaander, et al.
Acta Oncologica (Stockholm, Sweden)|August 2, 2018
Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancerRuben T H M Larue, Remy Klaassen, Arthur Jochems, et al.
European Journal of Anaesthesiology|December 3, 2019
Pulmonary levels of biomarkers for inflammation and lung injury in protective versus conventional one-lung ventilation for oesophagectomy: A randomised clinical trialMargaretha C van der Woude, Laura Bormans, Robrecht P van der Horst, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 11, 2019
Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinomaMartinus C J Anderegg, Jelle P Ruurda, Suzanne S Gisbertz, et al.
Acta Oncologica (Stockholm, Sweden)|September 9, 2017
Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom studyRuben T H M Larue, Janna E van Timmeren, Evelyn E C de Jong, et al.
Annals of Surgical Oncology|November 15, 2017
Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?Britt J P Hupkens, Monique Maas, Milou H Martens, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|March 1, 2023
Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: A population-based studySteven C Kuijper, Marieke Pape, Pauline A J Vissers, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 5, 2020
Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fieldsWillem J Koemans, Ruben T H M Larue, Maximilian Kloft, et al.
BMC Surgery|January 14, 2011
Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial)Surya Say Biere, Kirsten W Maas, Luigi Bonavina, et al.
The Annals of Thoracic Surgery|December 16, 2014
Leaving a mobilized thoracic esophagus in situ when incurable cancer is discovered intraoperativelyTeus J Weijs, Eelke L A Toxopeus, Jelle P Ruurda, et al.
JMIR Research Protocols|June 30, 2015
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and ProtocolBo Jan Noordman, Joel Shapiro, Manon Cw Spaander, et al.
Acta Oncologica (Stockholm, Sweden)|August 2, 2018
Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancerRuben T H M Larue, Remy Klaassen, Arthur Jochems, et al.
European Journal of Anaesthesiology|December 3, 2019
Pulmonary levels of biomarkers for inflammation and lung injury in protective versus conventional one-lung ventilation for oesophagectomy: A randomised clinical trialMargaretha C van der Woude, Laura Bormans, Robrecht P van der Horst, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 11, 2019
Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinomaMartinus C J Anderegg, Jelle P Ruurda, Suzanne S Gisbertz, et al.
Acta Oncologica (Stockholm, Sweden)|September 9, 2017
Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom studyRuben T H M Larue, Janna E van Timmeren, Evelyn E C de Jong, et al.
Annals of Surgical Oncology|November 15, 2017
Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?Britt J P Hupkens, Monique Maas, Milou H Martens, et al.
Pageof 6